Dow Up 0.12% Nasdaq Up 1.35%

More On IMV.V

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

ImmunoVaccine Inc. (IMV.V)

-TSXV
0.80 Down 0.03(3.61%) Oct 20
Prev Close:0.83
Open:0.83
Bid:0.78
Ask:0.82
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.79 - 0.86
52wk Range:0.30 - 1.50
Volume:121,316
Avg Vol (3m):360,086
Market Cap:63.64M
P/E (ttm):N/A
EPS (ttm):-0.07
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

» More Headlines for IMV.V

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunovaccine Inc., a clinical-stage biopharmaceutical company, discovers and develops activators of the immune system to treat cancer and prevent infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback